# Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.

> **NCT00171561** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 144 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** valsartan/hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00171561
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2011-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00171561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00171561, "Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00171561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*